A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The main purposes of this study are to evaluate the safety (Parts 1 and 2) and efficacy (Part
2) of pretreatment with CNTO 3157 in healthy adult and asthmatic adult participants before
and after intranasal (into the nose) inoculation with human rhinovirus type 16 (HRV-16).